Cardiac sarcoidosis (CS) is a rare but potentially fatal condition that may present with a wide
range of clinical manifestations including congestive heart failure, conduction abnormalities …

Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …

Sarcoidosis is a systemic granulomatous disease of unknown cause. Sarcoidosis involving
the heart, ie, cardiac sarcoidosis, affects the prognosis of patients significantly as it may lead …

Background Long‐term corticosteroid therapy is the standard of care for treatment of cardiac
sarcoidosis (CS). The efficacy of long‐term corticosteroid‐sparing immunosuppression in …

Cardiac sarcoidosis is a potentially life-threatening condition characterized by formation of
granulomas in the heart, resulting in conduction disturbances, atrial and ventricular …

Cardiac sarcoidosis (CS) is frequently difficult to treat. Infliximab (IFX) is useful for
extracardiac sarcoidosis, but its use in CS has been limited due to concerns about …

Clinically evident sarcoidosis involving the heart has been noted in at least 2 to 7% of
patients with sarcoidosis, but occult involvement is much higher (> 20%). Cardiac …

Background: In severe refractory sarcoidosis cases not responding to conventional
immunosuppressive treatment, the third-line tumor necrosis factor-alpha (TNF-α) inhibitors …

Cardiac sarcoidosis is an underdiagnosed disease that may be present in as many as 25%
of patients with systemic sarcoidosis. Although most commonly recognized in patients with …

Objective To assess the clinical characteristics, diagnosis, and outcome of cardiac
sarcoidosis in a single institution sarcoidosis clinic. Methods Patients with cardiac …